pharma · Transfusion Dependent Beta-Thalassaemia · Labor Induction
Guangzhou Virotech Pharmaceutical
Guangzhou Virotech Pharmaceutical Co.,
Guangzhou Virotech Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Transfusion Dependent Beta-Thalassaemia, Labor Induction. NovaPharmaNews links 2 clinical program(s)
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 2
- Patents
- 0
ET-01
Unknown · mab · Transfusion Dependent Beta-Thalassaemia
ET-01 for Transfusion Dependent Beta-Thalassaemia is a Unknown program (mab) at Guangzhou Virotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code EDI-001-002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Guangzhou Virotech Pharmaceutical Co.,
- Phase
- Unknown
- Modality
- mab
- Indication
- Transfusion Dependent Beta-Thalassaemia
- Status
- terminated
- Trials
- 1